| Trial ID: | L0573 |
| Source ID: | JPRN-UMIN000023574
|
| Associated Drug: |
SGLT2 inhibitor
|
| Title: |
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
NAFLD patients who were complicated with T2DM
|
| Interventions: |
Administration of 6 months of selective SGLT2 inhibitor.
|
| Outcome Measures: |
HbA1c after 6 months from the start of the administration.Body weight, body composition, ASTand ALT after 6 months from the start of the administration.
|
| Sponsor/Collaborators: |
Department of Hepatology, Shimane University Hospital
|
| Gender: |
All
|
| Age: |
20years-old80years-old
|
| Phases: |
Not applicable
|
| Enrollment: |
20
|
| Study Type: |
Interventional
|
| Study Designs: |
Single arm Non-randomized
|
| Start Date: |
09/08/2016
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
2 April 2019
|
| Locations: |
Japan
|
| URL: |
https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027149
|
